Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
China flag China · Delayed Price · Currency is CNY
100.69
+7.36 (7.89%)
At close: Mar 27, 2026

SHA:688266 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,0312,1542,110797.051,137
Trading Asset Securities
-40.5137.02248.9365.26
Cash & Short-Term Investments
2,0312,1942,2471,0461,202
Cash Growth
-7.43%-2.34%114.79%-12.97%-24.86%
Accounts Receivable
154.25143.63101.1488.9962.37
Other Receivables
10.279.3810.8912.5112.45
Receivables
164.52153.01112.03101.574.82
Inventory
173.27182.86110.8598.9851.91
Other Current Assets
74.1345.8550.7945.377.33
Total Current Assets
2,4432,5762,5201,2921,406
Property, Plant & Equipment
485.89363.43271.21247.09188.91
Long-Term Investments
--5.991010
Other Intangible Assets
30.5950.0169.2791.03116.29
Long-Term Deferred Charges
5.9811.3916.3920.9613.03
Other Long-Term Assets
3.633.884.027.4811.78
Total Assets
2,9693,0052,8871,6681,746
Accounts Payable
244.16197.1137.73151.72118.19
Accrued Expenses
77.1586.2282.0267.548.22
Short-Term Debt
989.05951.86795.16390.79131.81
Current Portion of Long-Term Debt
51.114.9750.5650.0430.03
Current Portion of Leases
-11.213.1713.6913.55
Current Income Taxes Payable
23.4220.9520.6420.2918.58
Current Unearned Revenue
1.25--0.280.36
Other Current Liabilities
41.8101.1535.8934.8820.16
Total Current Liabilities
1,4281,3731,135729.19380.89
Long-Term Debt
8444.35-50.09-
Long-Term Leases
8.626.8629.4643.1848.18
Long-Term Unearned Revenue
8.079.211.5545.0448.05
Long-Term Deferred Tax Liabilities
1.645.79.5813.3215.77
Other Long-Term Liabilities
358.49292.4556.6--
Total Liabilities
1,8891,7521,242880.82492.88
Common Stock
264.71264.71264.71240240
Additional Paid-In Capital
3,1093,1203,3532,2222,205
Retained Earnings
-2,280-2,117-1,979-1,700-1,243
Comprehensive Income & Other
-14.05-14.47-5.95-2.84-6.32
Total Common Equity
1,0801,2541,633759.121,196
Minority Interest
--1.2611.9828.3756.76
Shareholders' Equity
1,0801,2531,645787.491,253
Total Liabilities & Equity
2,9693,0052,8871,6681,746
Total Debt
1,1331,039888.35547.8223.57
Net Cash (Debt)
898.421,1551,358498.18978.32
Net Cash Growth
-22.21%-14.97%172.65%-49.08%-36.78%
Net Cash Per Share
3.424.365.312.084.08
Filing Date Shares Outstanding
264.71264.71264.71264.49240
Total Common Shares Outstanding
264.71264.71264.71240240
Working Capital
1,0151,2021,385562.571,025
Book Value Per Share
4.084.746.173.164.98
Tangible Book Value
1,0501,2041,564668.091,080
Tangible Book Value Per Share
3.974.555.912.784.50
Buildings
-135.2641.9341.9341.21
Machinery
-145.53120.48121.7496.02
Construction In Progress
-123.47135.8386.6727.25
Source: S&P Global Market Intelligence. Standard template. Financial Sources.